On November 30, the fourth batch of state-organized high-value medical consumables centralized procurement was opened in Tianjin, resulting in the proposed winning results. This centralized procurement covers high-value medical consumables related to intraocular lenses and sports medicine, and the average price of the selected products is reduced by about 70%.
According to the calculation before centralized procurement, the market size of this centralized procurement product is about 15.5 billion yuan. Among them, there are 11 varieties of intraocular lens consumables, with a total of 6.5 billion yuan;There are 19 varieties of sports medicine consumables, with a total of 9 billion yuan. Among the selected products in this centralized procurement, the average price of intraocular lens consumables is reduced by 60%, which is expected to save 3.9 billion yuan per yearThe average price of sports medicine consumables has been reduced by 74%, which is expected to save 6.7 billion yuan per year.
This centralized procurement has widely benefited cataract patients who have received lens implantation, as well as patients who need sports medicine surgery due to labor and sports muscle and ligament damage, and the masses have a strong sense of gain.
A total of 128 companies participated in this centralized procurement, and 126 companies planned to be selected, with a selection rate of 98%. The leading enterprises at home and abroad with high market share have selected their products, which maintain the stability of clinical use and the most diversified products.
Alcon of the United States this year launched a new depth of field extension crystal from 110,000 yuan to more than 3,500 yuan, high-performance trifocal crystals (non-astigmatism) from 230,000 yuan to more than 8,900 yuan
The non-astigmatism monofocal lens of the domestic enterprise Aibo Nord is the most demanded intraocular lens product, which has dropped from 2,500 yuan to nearly 800 yuan
Johnson & Johnson's new generation of monofocal crystals has dropped from 10,000 yuan to more than 1,100 yuan
The British company is a well-known enterprise in the field of global sports medicine, and its product polyetheretherketone belt anchor has dropped from 5,600 yuan to more than 1,300 yuan
The amount of artificial bone that is widely used in clinical practice and easy to abuse has dropped from 1400 yuan to more than 300 yuan.
In the next step, the National Health Insurance Administration will work with relevant departments to guide all localities and selected enterprises to do a good job in the implementation of the selection resultsEnsure that patients across the country can use the selected products after the price reduction from May to June 2024.
*: CCTV News.